版本:
中国

BRIEF-Titan Pharmaceuticals reports Q1 loss per share $0.14

May 10 Titan Pharmaceuticals Inc:

* Titan pharmaceuticals reports first quarter 2017 financial results

* Q1 loss per share $0.14

* Titan Pharmaceuticals Inc - Titan is on track to submit an MAA to EMA in Q4 of 2017

* Titan Pharmaceuticals Inc - at March 31, 2017 titan had cash and cash equivalents of approximately $10.9 million

* Titan Pharmaceuticals Inc - company believes is sufficient to fund planned operations through Q2 of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐